- Home
- MDGL vs PAYP Comparison
MDGL vs PAYP Comparison
Compare MDGL & PAYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | PAYP |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.9B |
| IPO Year | 2005 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MDGL | PAYP |
|---|---|---|
| Price | $508.53 | $14.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $674.45 | $25.54 |
| AVG Volume (30 Days) | 262.9K | ★ 1.4M |
| Earning Date | 05-06-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | N/A |
| Revenue Next Year | $48.55 | $20.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $284.02 | $12.07 |
| 52 Week High | $615.00 | $24.89 |
Technical Indicators
Market Signals| Indicator | MDGL | PAYP |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 39.34 |
| Support Level | $498.59 | N/A |
| Resistance Level | $540.72 | $23.11 |
| Average True Range (ATR) | 17.55 | 1.03 |
| MACD | 3.74 | 0.09 |
| Stochastic Oscillator | 70.79 | 47.12 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About PAYP PayPay Corporation American Depository Shares
PayPay is a fintech company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.